Sutmuller R - Search Results

1

Regulatory T cells and toll-like receptors: regulating the regulators.

Sutmuller R, Garritsen A, Adema GJ. Sutmuller R, et al. Ann Rheum Dis. 2007 Nov;66 Suppl 3(Suppl 3):iii91-5. doi: 10.1136/ard.2007.078535. Ann Rheum Dis. 2007. PMID: 17934105 Free PMC article. Review.

2

Toll-like receptors on regulatory T cells: expanding immune regulation.

Sutmuller RP, Morgan ME, Netea MG, Grauer O, Adema GJ. Sutmuller RP, et al. Trends Immunol. 2006 Aug;27(8):387-93. doi: 10.1016/j.it.2006.06.005. Epub 2006 Jun 30. Trends Immunol. 2006. PMID: 16814607 Review.

3

From the Th1/Th2 paradigm towards a Toll-like receptor/T-helper bias.

Netea MG, Van der Meer JW, Sutmuller RP, Adema GJ, Kullberg BJ. Netea MG, et al. Antimicrob Agents Chemother. 2005 Oct;49(10):3991-6. doi: 10.1128/AAC.49.10.3991-3996.2005. Antimicrob Agents Chemother. 2005. PMID: 16189071 Free PMC article. Review. No abstract available.

4

Toll-like receptor 2 suppresses immunity against Candida albicans through induction of IL-10 and regulatory T cells.

Netea MG, Sutmuller R, Hermann C, Van der Graaf CA, Van der Meer JW, van Krieken JH, Hartung T, Adema G, Kullberg BJ. Netea MG, et al. Among authors: sutmuller r. J Immunol. 2004 Mar 15;172(6):3712-8. doi: 10.4049/jimmunol.172.6.3712. J Immunol. 2004. PMID: 15004175

5

Toll-like receptor 2 controls expansion and function of regulatory T cells.

Sutmuller RP, den Brok MH, Kramer M, Bennink EJ, Toonen LW, Kullberg BJ, Joosten LA, Akira S, Netea MG, Adema GJ. Sutmuller RP, et al. J Clin Invest. 2006 Feb;116(2):485-94. doi: 10.1172/JCI25439. Epub 2006 Jan 19. J Clin Invest. 2006. PMID: 16424940 Free PMC article.

6

CD4+FoxP3+ regulatory T cells gradually accumulate in gliomas during tumor growth and efficiently suppress antiglioma immune responses in vivo.

Grauer OM, Nierkens S, Bennink E, Toonen LW, Boon L, Wesseling P, Sutmuller RP, Adema GJ. Grauer OM, et al. Among authors: sutmuller rp. Int J Cancer. 2007 Jul 1;121(1):95-105. doi: 10.1002/ijc.22607. Int J Cancer. 2007. PMID: 17315190 Free article.

7

Elimination of regulatory T cells is essential for an effective vaccination with tumor lysate-pulsed dendritic cells in a murine glioma model.

Grauer OM, Sutmuller RP, van Maren W, Jacobs JF, Bennink E, Toonen LW, Nierkens S, Adema GJ. Grauer OM, et al. Among authors: sutmuller rp. Int J Cancer. 2008 Apr 15;122(8):1794-802. doi: 10.1002/ijc.23284. Int J Cancer. 2008. PMID: 18076066 Free article.

8

Multifaceted effects of synthetic TLR2 ligand and Legionella pneumophilia on Treg-mediated suppression of T cell activation.

van Maren WW, Nierkens S, Toonen LW, Bolscher JM, Sutmuller RP, Adema GJ. van Maren WW, et al. Among authors: sutmuller rp. BMC Immunol. 2011 Mar 24;12:23. doi: 10.1186/1471-2172-12-23. BMC Immunol. 2011. PMID: 21435210 Free PMC article.

9

Dendritic cell vaccination in combination with anti-CD25 monoclonal antibody treatment: a phase I/II study in metastatic melanoma patients.

Jacobs JF, Punt CJ, Lesterhuis WJ, Sutmuller RP, Brouwer HM, Scharenborg NM, Klasen IS, Hilbrands LB, Figdor CG, de Vries IJ, Adema GJ. Jacobs JF, et al. Among authors: sutmuller rp. Clin Cancer Res. 2010 Oct 15;16(20):5067-78. doi: 10.1158/1078-0432.CCR-10-1757. Epub 2010 Aug 24. Clin Cancer Res. 2010. PMID: 20736326 Clinical Trial.

10

Synergy between in situ cryoablation and TLR9 stimulation results in a highly effective in vivo dendritic cell vaccine.

den Brok MH, Sutmuller RP, Nierkens S, Bennink EJ, Toonen LW, Figdor CG, Ruers TJ, Adema GJ. den Brok MH, et al. Cancer Res. 2006 Jul 15;66(14):7285-92. doi: 10.1158/0008-5472.CAN-06-0206. Cancer Res. 2006. PMID: 16849578

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

30 results

Search Page